Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Turning Point Therapeutics, Inc.
Eastern Cooperative Oncology Group
City of Hope Medical Center
Washington University School of Medicine
University of Nebraska
Var2 Pharmaceuticals
Washington University School of Medicine
GONGCHU Biotechnology Co., Ltd
Gustave Roussy, Cancer Campus, Grand Paris
Institut du Cancer de Montpellier - Val d'Aurelle
Stanford University
European Organisation for Research and Treatment of Cancer - EORTC